BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

Completed · Not applicable

Conditions studied: Sinus Node Dysfunction, Bradycardia, Atrioventricular Block

In brief

The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia CSP S pacing lead when implanted in the left bundle branch area (LBBA). Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post-implant. Efficacy will be assessed by evaluating implant success rate.

Key facts

Study ID
NCT06540079
Run by
Biotronik, Inc.
People needed
192
Starts
2024-12-18
Expected to finish
2026-06-17
Last updated by the study team
2026-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.